Elanco Animal (Germany) Top Insiders

5EA Stock  EUR 11.90  0.19  1.57%   
Elanco Animal employs about 27 people. The company is managed by 26 executives with a total tenure of roughly 100 years, averaging almost 3.0 years of service per executive, having 1.04 employees per reported executive. Examination of Elanco Animal's management performance can provide insight into the company performance.
Jeffrey Simmons  CEO
President, Chief Executive Officer, Director
Sarena Lin  President
Executive Vice President, Global Marketing, Corporate Strategy and Transformation
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Elanco Animal Management Team Effectiveness

The company has return on total asset (ROA) of 0.0189 % which means that it generated a profit of $0.0189 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0104) %, meaning that it generated substantial loss on money invested by shareholders. Elanco Animal's management efficiency ratios could be used to measure how well Elanco Animal manages its routine affairs as well as how well it operates its assets and liabilities.

Elanco Animal Workforce Comparison

Elanco Animal Health is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 102,037. Elanco Animal adds roughly 27.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09.

Elanco Animal Health Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Elanco Animal Health Price Series Summation is a cross summation of Elanco Animal price series and its benchmark/peer.

Elanco Animal Notable Stakeholders

An Elanco Animal stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Elanco Animal often face trade-offs trying to please all of them. Elanco Animal's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Elanco Animal's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jeffrey SimmonsPresident, Chief Executive Officer, DirectorProfile
Sarena LinExecutive Vice President, Global Marketing, Corporate Strategy and TransformationProfile
James MeerChief Accounting Officer, Vice PresidentProfile
Todd YoungChief Financial Officer, Executive Vice PresidentProfile
Art GarciaIndependent DirectorProfile
Joshua SmileyIndependent DirectorProfile
Chris KeeleyVP OfficerProfile
Carl McMillianIndependent DirectorProfile
Denise ScotsKnightIndependent DirectorProfile
David KinardExecutive Vice President of Human ResourcesProfile
David UrbanekExecutive Vice President - Manufacturing, QualityProfile
Aaron SchachtExecutive Vice President - Innovation, Regulatory, Business DevelopmentProfile
R HooverIndependent Chairman of the BoardProfile
Larbi LierVP AsiaProfile
Kirk McDonaldIndependent DirectorProfile
Kapila AnandIndependent DirectorProfile
Michael HarringtonIndependent DirectorProfile
David RicksIndependent DirectorProfile
Marcela KirbergerGen VPProfile
Shawn McKeeSr AnimalProfile
Deborah KochevarIndependent DirectorProfile
Lawrence KurziusIndependent DirectorProfile
Ramiro CabralExecutive Vice President - Elanco InternationalProfile
Aarti ShahIndependent DirectorProfile
John BilbreyIndependent DirectorProfile
MichaelBryant HicksExecutive Vice President General Counsel, Corporate SecretaryProfile

About Elanco Animal Management Performance

The success or failure of an entity such as Elanco Animal Health often depends on how effective the management is. Elanco Animal management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Elanco management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Elanco management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. ELANCO ANIMAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10200 people.

Elanco Animal Workforce Analysis

Traditionally, organizations such as Elanco Animal use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Elanco Animal within its industry.

Elanco Animal Manpower Efficiency

Return on Elanco Animal Manpower

Revenue Per Employee163.6M
Revenue Per Executive169.9M
Net Loss Per Employee2.7M
Net Loss Per Executive2.8M

Complementary Tools for Elanco Stock analysis

When running Elanco Animal's price analysis, check to measure Elanco Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elanco Animal is operating at the current time. Most of Elanco Animal's value examination focuses on studying past and present price action to predict the probability of Elanco Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elanco Animal's price. Additionally, you may evaluate how the addition of Elanco Animal to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk